My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Contributor

Location

Published Date

Displaying 4 results for

GO
Search Filters: Policy cancel Infectious Disease cancel COVID and Communication cancel

Resiliency, Communication, and Partnerships: Insights From the de Beaumont Foundation

Infectious Disease,
COVID-19,
COVID and Communication,
COVID and Healthcare Systems,
COVID and Workforce,
Partnership,
Policy,
Federal Government Affairs,
Leadership and Workforce Development,
Immunization,
Vaccine Distribution,
Vaccine Hesitancy,
COVID Vaccine,
Blog,
People of Public Health,
Mark Miller,
Mattie Quinn,
Public Health Workforce

Throughout the COVID-19 pandemic, the de Beaumont Foundation has worked closely with organizations like ASTHO to support and strengthen public health. The foundation has produced several publications and guides to support public health ...

FDA’s Approval of the Pfizer-BioNTech COVID-19 Vaccine: Five Things to Know

Infectious Disease,
COVID-19,
COVID Vaccine,
COVID and Communication,
Immunization,
Vaccine Distribution,
Vaccine Hesitancy,
Emerging Infectious Diseases,
Policy,
Federal Government Affairs,
Blog,
Preparedness,
Meredith Allen,
COVID and Law/Policy

On Aug. 23, 2021, the FDA announced full approval of Pfizer and BioNTech’s mRNA vaccine for COVID-19. ASTHO has answers to five key questions about the approval and what it means for state and territorial health officials: What does the ...

Getting Ahead of the COVID-19 Vaccine

Blog,
Health Policy Update,
Infectious Disease,
COVID-19,
COVID Vaccine,
Immunization,
Vaccine Distribution,
Vaccine Hesitancy,
Public Health Infrastructure and Systems Improvement,
Public Health Infrastructure and Systems Improvement,
Health Equity,
At-Risk Populations,
Communications,
Policy,
State Health Policy,
California,
Louisiana,
New Hampshire,
New York,
West Virginia,
Leah Silva,
COVID and Communication

Scientists are working quickly to develop a safe and effective vaccine to provide immunity to COVID-19. Once a vaccine is approved, it will likely be imperative for states to authorize as many health care professionals to administer it, ...

What You Need to Know About the COVID-19 Vaccine

Blog,
Health Policy Update,
Infectious Disease,
COVID-19,
COVID Vaccine,
COVID and Healthcare Systems,
COVID and Law/Policy,
Policy,
Federal Government Affairs,
COVID and Communication,
Immunization,
Vaccine Distribution,
Vaccine Hesitancy,
Preparedness,
Pandemics,
Public Health Infrastructure and Systems Improvement,
Public Health Infrastructure and Systems Improvement,
Accreditation,
Emma Lange

Many pharmaceutical companies urgently began developing a COVID-19 vaccine earlier this year to reduce the spread of the virus as the threat of a pandemic loomed. Fast forward several months and millions of COVID-19 cases later, states and ...